Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
Source: US Top News and Analysis
Related Posts
How to trade the key earnings of the week from NYSE insider Jay Woods
In a weekly video to CNBC PRO subscribers, Woods highlighted upcoming earnings from both Delta…
Trump praises Hungary PM Viktor Orban after Vance calls him at Budapest rally
Vance said he was not there to tell Hungarians how to vote, but later told…
Jeep maker Stellantis beats expectations as first-quarter operating income tops $1 billion
The multinational conglomerate posted first-quarter adjusted operating income of 960 million euros ($1.19 billion), comfortably…